| NASDAQ: FLXN|
| FLXN (NASDAQ) US$ 20.73 +0.10 (+0.48%)10 Mar, 4:00 PM GMT-5 - Disclaimer|
Burlington, Massachusetts, United States
Flexion Therapeutics Wikipedia
Flexion Therapeutics is an American biotechnology company based in Burlington, Massachusetts that is developing long-lasting intra-articular injection therapies for the treatment of osteoarthritis. As of May 2012 Flexion was developing three new drug candidates:FX005 is a sustained release, intra-articular p38 mitogen-activated protein kinase (p38 MAP) inhibitor,
Zilretta (FX006) is a sustained release, intra-articular steroid, that has received FDA Fast Track Designation to treat pain from osteoarthritis of the knee.
FX007 is a sustained release, intra-articular TrkA receptor antagonist.